Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Michaelis

Emergency Medicine Mount Pleasant, SC Doctor of Osteopathy

NPI 1174715809 CMS profile 994985

180 Wingo Way Ste 101, Mount Pleasant, SC 29464

Open in the dashboard

General payments

$398,548

439 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$85,000 paid to institutions, not to them · program year 2024

Through program year 2025, Christopher Michaelis of Mount Pleasant, SC is reported in the CMS Open Payments database as having received $398,548 across 439 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $85,000 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $236,649 71
2024 General $108,123 137
2023 General $9,711 44
2022 General $13,915 36
2021 General $1,052 54
2020 General $1,657 41
2019 General $27,442 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Michaelis
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Christopher Michaelis were reported at $236,649. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Christopher Michaelis Emergency Medicine median Middle half National median
2019 $27,442 $51 $18–$128 $163
2020 $1,657 $29 $16–$99 $114
2021 $1,052 $40 $18–$124 $132
2022 $13,915 $49 $20–$134 $149
2023 $9,711 $51 $22–$142 $160
2024 $108,123 $52 $22–$150 $164
2025 $236,649 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ConvaTec Inc. $352,215 192 payments
  2. Organogenesis Inc. $30,326 111 payments
  3. Triad Life Sciences Inc. $13,301 12 payments
  4. Smith+Nephew, Inc. $759 46 payments
  5. Misonix Inc $533 37 payments
  6. Epsfl, LLC $269 1 payment
  7. Vaporox, Inc. $219 1 payment
  8. Kerecis Limited $146 5 payments
  9. KCI USA, Inc $142 6 payments
  10. Paratek Pharmaceuticals, Inc. $113 7 payments
  11. Other $526 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Debt forgiveness $328,170 154 payments
  2. Consulting Fee $30,178 11 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,569 32 payments
  4. Food and Beverage $7,749 224 payments
  5. Travel and Lodging $5,083 17 payments
  6. Honoraria $800 1 payment
Products named General payments · program years 2019–2025
  1. INNOVAMATRIX AC $358,910 199 payments
  2. Apligraf Podiatry $26,637 33 payments
  3. Puraply/Affinity/NuTech $26,637 33 payments
  4. Dermagraft $26,637 33 payments
  5. NOVAFIX $6,400 2 payments
  6. Puraply $2,321 44 payments
  7. Affinity $318 5 payments
  8. Apligraf Wound Care $306 9 payments
  9. COLLAGENASE SANTYL $273 20 payments
  10. VHT-200 Wound Treatment System $219 1 payment
  11. Other $3,077 112 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

88

Median for Osteopathic Manipulative Medicine: 311

Drug cost

$68,963

Median for Osteopathic Manipulative Medicine: $11,323

Branded share of claims

45.5%

Median for Osteopathic Manipulative Medicine: 19.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Santyl Collagenase Clostridium Hist. Brand 40 $47,596
Tobramycin Sulfate Generic 11 $20,688
Metronidazole Generic 14 $478
Doxycycline Hyclate Generic 23 $201

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 526 Part D prescribers listed as Osteopathic Manipulative Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$1,340,040

Of which drugs: $651,931

Medicare patients

290

Average age 77

Services billed

5,094

143 women, 147 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 66%
Diabetes 47%
Chronic kidney disease 40%
Ischemic heart disease 38%
Heart failure 36%
Atrial fibrillation 34%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

439 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record